Conglobatin (6.25-100 μM; 48 h) markedly inhibits the proliferation of SKBR3 and MCF-7 cells, with IC50s of 12.11 and 39.44 μM, respectively.
Conglobatin inhibits cell proliferation in EC109, KYSE70, KYSE450, KYSE150, KYSE180, and KYSE510 cells, with IC50s of 16.43, 15.89, 10.94, 10.50, 10.28, and 9.31 μM, respectively.
Conglobatin (10-40 μM; 24 h) displays obvious arrest of SKBR3 and MCF-7 cells in the G2/M phase. Conglobatin induces apoptosis through caspase-dependent pathways in SKBR3 and MCF-7 cells.
Conglobatin (10-40 μM; 3-24 h) reduces Hsp90 client protein levels and induces proteasome-dependent degradation.
Conglobatin binds to the N-terminal of Hsp90, does not affect ATP-binding capability of Hsp90, but inhibits Hsp90/Cdc37 chaperone/co-chaperone interactions.
Cell Proliferation Assay
Cell Line: |
SKBR3 and MCF-7 cells |
Concentration: |
6.25, 12.5, 25, 50, 100 μM |
Incubation Time: |
48 hours |
Result: |
Inhibited the proliferation of SKBR3 and MCF-7 cells in a dose-dependent manner. |
Cell Cycle Analysis
Cell Line: |
SKBR3 and MCF-7 cells |
Concentration: |
10, 20, 40 μM |
Incubation Time: |
24 hours |
Result: |
Increased the G2/M cell population and decreased the population in the S and G0/G1 phases. |
Western Blot Analysis
Cell Line: |
SKBR3 and MCF-7 cells |
Concentration: |
10, 20, 40 μM |
Incubation Time: |
3, 6, 12, 24 hours |
Result: |
Decreased the levels of the client proteins HER2, p-HER2, Raf-1, Akt, and p-Akt in a dose and time-dependent manner in SKBR3 cells.
Reduced the the levels of the client proteins Raf-1, Akt, and p-Akt in a dose and time-dependent manner in MCF-7 cells. |